Literature DB >> 14523377

SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan.

Hiba Salah Mohamed1, Muntaser Eltayeb Ibrahim, Elinor Nancy Miller, Jacqueline Katie White, Heather Jane Cordell, Joanna McCammond McGill Howson, Christopher Sean Peacock, Eltahir Awad Gasim Khalil, Ahmed Mohamed El Hassan, Jenefer Mary Blackwell.   

Abstract

Genetic susceptibility to visceral leishmaniasis (VL) is indicated by differences in incidence and clinical phenotypes between ethnic groups in Sudan. In mice, innate susceptibility to Leishmania donovani, the etiological agent of VL, is controlled by Slc11a1 (formerly Nramp1). We therefore examined polymorphisms at SLC11A1 in 59 multicase families of VL from the high-incidence Masalit tribe in Sudan. Multipoint nonparametric analysis in ALLEGRO shows a significant linkage across SLC11A1 (Zlr scores 2.38-2.55; 0.008< or =P< or =0.012; information content 0.88). The extended transmission disequilibrium test shows biased transmission of alleles at 5' polymorphisms in the promoter (P=0.0145), exon 3 (P=0.0037) and intron 4 (P=0.0049), and haplotypes formed by them (P=0.0089), but not for 3' polymorphisms at exon 15 or the 3'UTR. Stepwise logistic regression analysis using a case/pseudo-control data set derived from the 59 families was consistent with main effects contributed by the intron 4 469+14G/C polymorphism. Although the two alleles for 469+14G/C lie on haplotypes carrying different alleles for the functional promoter GTn polymorphism, the latter did not itself contribute separate main effects. Sequence analysis of 36 individuals failed to identify new putative functional polymorphisms in the coding region, intron 1, intron/exon boundaries, intron 4/exon 4a, or in the 3'UTR. One novel promoter polymorphism (-86G/A) was located within a putative nuclear factor kappa B binding site that could be functional. Further work will determine whether additional polymorphisms occur upstream in the promoter, which could be in linkage disequilibrium with the intron 4 polymorphism. These studies contribute to knowledge of the role of SLC11A1 in infectious disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14523377     DOI: 10.1038/sj.ejhg.5201089

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  37 in total

1.  Fine mapping of Leishmania major susceptibility Locus lmr2 and evidence of a role for Fli1 in disease and wound healing.

Authors:  Anuratha Sakthianandeswaren; Joan M Curtis; Colleen Elso; Beena Kumar; Tracey M Baldwin; Sash Lopaticki; Lukasz Kedzierski; Gordon K Smyth; Simon J Foote; Emanuela Handman
Journal:  Infect Immun       Date:  2010-04-05       Impact factor: 3.441

2.  SLC11A1 polymorphisms in inflammatory bowel disease and Mycobacterium avium subspecies paratuberculosis status.

Authors:  Lucy C Stewart; Andrew S Day; John Pearson; Murray L Barclay; Richard B Gearry; Rebecca L Roberts; Robert W Bentley
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

3.  Transmembrane molecules for phylogenetic analyses of pathogenic protists: Leishmania-specific informative sites in hydrophilic loops of trans- endoplasmic reticulum N-acetylglucosamine-1-phosphate transferase.

Authors:  Kayoko Waki; Sujoy Dutta; Debalina Ray; Bala Krishna Kolli; Leyla Akman; Shin-Ichiro Kawazu; Chung-Ping Lin; Kwang-Poo Chang
Journal:  Eukaryot Cell       Date:  2006-12-01

4.  RNA-binding protein HuR is required for stabilization of SLC11A1 mRNA and SLC11A1 protein expression.

Authors:  Yong Zhong Xu; Sergio Di Marco; Imed Gallouzi; Marek Rola-Pleszczynski; Danuta Radzioch
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

5.  Asymptomatic Leishmania infection: a new challenge for Leishmania control.

Authors:  Om Prakash Singh; Epco Hasker; David Sacks; Marleen Boelaert; Shyam Sundar
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

6.  Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection.

Authors:  S M B Jeronimo; A K B Holst; S E Jamieson; R Francis; D R A Martins; F L Bezerra; N A Ettinger; E T Nascimento; G R Monteiro; H G Lacerda; E N Miller; H J Cordell; P Duggal; T H Beaty; J M Blackwell; M E Wilson
Journal:  Genes Immun       Date:  2007-08-23       Impact factor: 2.676

7.  NRAMP1 (SLC11A1): a plausible candidate gene for systemic sclerosis (SSc) with interstitial lung involvement.

Authors:  O Ates; B Müsellim; G Ongen; A Topal-Sarikaya
Journal:  J Clin Immunol       Date:  2007-09-18       Impact factor: 8.317

Review 8.  Interdependence of hypoxic and innate immune responses.

Authors:  Victor Nizet; Randall S Johnson
Journal:  Nat Rev Immunol       Date:  2009-09       Impact factor: 53.106

Review 9.  Genetics and visceral leishmaniasis: of mice and man.

Authors:  J M Blackwell; M Fakiola; M E Ibrahim; S E Jamieson; S B Jeronimo; E N Miller; A Mishra; H S Mohamed; C S Peacock; M Raju; S Sundar; M E Wilson
Journal:  Parasite Immunol       Date:  2009-05       Impact factor: 2.280

10.  CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study.

Authors:  Léa Castellucci; Sarra E Jamieson; E Nancy Miller; Eliane Menezes; Joyce Oliveira; Andrea Magalhães; Luiz Henrique Guimarães; Marcus Lessa; Amélia Ribeiro de Jesus; Edgar M Carvalho; Jenefer M Blackwell
Journal:  BMC Med Genet       Date:  2010-01-20       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.